Khan Najat 4
4 · RECURSION PHARMACEUTICALS, INC. · Filed Aug 19, 2025
Insider Transaction Report
Form 4
Khan Najat
DirectorCEO and President
Transactions
- Tax Payment
Class A Common Stock
2025-08-15$5.64/sh−3,789$21,370→ 704,796 total - Sale
Class A Common Stock
2025-08-18$5.52/sh−36,599$202,173→ 668,197 total
Footnotes (2)
- [F1]Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units.
- [F2]Represents shares that have been required to be sold by the Issuer to satisfy the tax withholding and remittance obligations in connection with the vesting of restricted stock units.